Загрузка...
Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: A case report
Hepatocellular carcinoma is rare, but increasing in prevalence in the United States. Recent studies have shown that sorafenib, a multikinase inhibitor, can reduce tumor progression in patients with this cancer. However, complete remission has not been observed. We report a case of a 78-year old pati...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2008
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2575202/ https://ncbi.nlm.nih.gov/pubmed/18928548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-1-18 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|